Zhejiang Dayang Biotech Group Co (003017) — Strategic Asset Allocation Index
Zhejiang Dayang Biotech Group Co (003017) has a Strategic Asset Allocation Index of 62.7% as of June 2023. Strategic assets (PP&E of CN¥631.19 Million plus long-term investments of CN¥-) total CN¥631.19 Million, measured against net assets of CN¥1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Zhejiang Dayang Biotech Group Co liquidity resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Dayang Biotech Group Co Strategic Asset Allocation Index (2016–2022)
This chart shows how Zhejiang Dayang Biotech Group Co's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.7%, representing strategic assets of CN¥631.19 Million against net assets of CN¥1.01 Billion CNY. See 003017 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Zhejiang Dayang Biotech Group Co (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Dayang Biotech Group Co from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zhejiang Dayang Biotech Group Co stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.6% | CN¥616.17 Million | CN¥616.17 Million | CN¥- | CN¥985.05 Million | ▲ +9.3 pp |
| 2021 | 53.3% | CN¥528.02 Million | CN¥528.02 Million | CN¥- | CN¥990.71 Million | ▲ +8.0 pp |
| 2020 | 45.3% | CN¥433.57 Million | CN¥433.57 Million | CN¥- | CN¥958.13 Million | ▼ -9.8 pp |
| 2019 | 55.0% | CN¥274.17 Million | CN¥274.17 Million | CN¥- | CN¥498.09 Million | ▼ -1.2 pp |
| 2018 | 56.2% | CN¥247.65 Million | CN¥247.65 Million | CN¥- | CN¥440.62 Million | ▼ -9.5 pp |
| 2017 | 65.7% | CN¥221.81 Million | CN¥221.81 Million | CN¥- | CN¥337.71 Million | ▼ -20.9 pp |
| 2016 | 86.6% | CN¥198.55 Million | CN¥198.55 Million | CN¥- | CN¥229.35 Million | — |